Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
InChiKey: PXZFKAKWSHBDCP-UHFFFAOYSA-N
A dual CCR2/CCR5 chemokine antagonist
4-dimethyl-5-[(2-oxo-2
but decreases the plasma lysophosphatidylcholine concentration
Linagliptin Catalog No.:M10654-10 InChiKey: PXZFKAKWSHBDCP-UHFFFAOYSA-NLinagliptin, also known as BI 1356, is a DPP 4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly. Product information CAS Number: 668270 12 0 Molecular Weight: 472. 54 Formula: C25H28N8O2 Chemical Name: 8 [(3R) 3 aminopiperidin 1 yl] 7 (but 2 yn 1 yl) 3 methyl 1 [(4
US$ 14.99
US$ 244.97
US$ 14.99
US$ 11.99
US$ 12.99